Rivaroxaban is a new oral anticoagulant drug indicated for adult patients with nonvalvular atrial fibrillation (except atrial fibrillation due to rheumatic valvular heart disease and atrial fibrillation after heart valve replacement) to reduce the risk of stroke and systemic embolism.

CAS NO:  366789-02-8

Melting Point:  228-229°C

Boiling Point: 732.6±60.0°C(Predicted)

Density： 1.460±0.06g/cm3(Predicted)

Storage condition： Inert atmosphere,2-8°C

Solubility: insoluble in H2O; insoluble in EtOH;≥13.9mg/mL in DMSO with gentle warming

Form: solid

Acidity coefficient: (pKa)13.36±0.46(Predicted)